Armistice Capital, LLC 13D and 13G filings for PHAXIAM Therapeutics S.A.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 12:41 pm Sale |
2022-12-31 | 13G | PHAXIAM Therapeutics S.A. PHXM |
Armistice Capital, LLC | 162,912 4.990% |
-110,813 (-40.48%) |
Filing |
| 2022-02-14 6:28 pm Purchase |
2021-12-31 | 13G | PHAXIAM Therapeutics S.A. PHXM |
Armistice Capital, LLC | 273,725 9.300% |
273,725 (New Position) |
Filing |